Overexpression of PART1, SNHG11, LINC00173 and MIR17HG is widely involved in tumorigenesis and malignant progression of several types of cancer, such as glioma, breast cancer, lung cancer and colorectal cancer [48–52]. Here, MIR17HG is linked to lung cancer.